Quetiapine

Role

Indications

Reactions

Primary

Product Used For Unknown Indication	29.5%
Bipolar Disorder	14.0%
Depression	11.7%
Schizophrenia	8.8%
Psychotic Disorder	8.0%
Schizoaffective Disorder	3.6%
Anxiety	3.4%
Major Depression	3.4%
Insomnia	2.1%
Obsessive-compulsive Disorder	1.9%
Mania	1.9%
Hypertension	1.8%
Agitation	1.7%
Affective Disorder	1.4%
Bipolar I Disorder	1.3%
Bipolar Ii Disorder	1.2%
Personality Disorder	1.1%
Schizophrenia, Paranoid Type	1.1%
Drug Use For Unknown Indication	1.0%
Delirium	1.0%

Completed Suicide	24.5%
Toxicity To Various Agents	21.0%
Sudden Cardiac Death	4.8%
Overdose	4.7%
Death	4.3%
Cardio-respiratory Arrest	3.3%
Neutropenia	3.3%
Pulmonary Embolism	3.3%
Drug Interaction	3.1%
Product Substitution Issue	3.1%
Rhabdomyolysis	3.1%
Somnolence	2.9%
Sedation	2.8%
Weight Increased	2.8%
Drug Toxicity	2.6%
Suicide Attempt	2.4%
Unresponsive To Stimuli	2.2%
Psychotic Disorder	2.1%
Supraventricular Tachycardia	1.9%
Vision Blurred	1.9%

Secondary

Product Used For Unknown Indication	43.0%
Drug Use For Unknown Indication	13.4%
Depression	7.5%
Bipolar Disorder	7.1%
Psychotic Disorder	5.9%
Schizophrenia	4.5%
Suicide Attempt	2.9%
Drug Abuse	2.3%
Anxiety	1.7%
Obsessive-compulsive Disorder	1.7%
Mania	1.6%
Insomnia	1.4%
Parkinson's Disease	1.2%
Schizoaffective Disorder	1.2%
Major Depression	1.2%
Overdose	0.8%
Agitation	0.7%
Personality Disorder	0.7%
Dementia	0.6%
Pain	0.6%

Completed Suicide	26.9%
Toxicity To Various Agents	10.9%
Respiratory Arrest	7.3%
Death	6.9%
Poisoning	5.1%
Drug Toxicity	4.5%
Drug Abuse	4.3%
Overdose	3.7%
Serotonin Syndrome	3.5%
Cardio-respiratory Arrest	3.4%
Suicide Attempt	3.2%
Weight Increased	2.9%
Vitreous Floaters	2.5%
Rhabdomyolysis	2.5%
Neuroleptic Malignant Syndrome	2.2%
Cardiac Arrest	2.2%
Somnolence	2.2%
Drug Ineffective	2.0%
Vomiting	2.0%
Pulmonary Embolism	1.8%

Concomitant

Product Used For Unknown Indication	30.6%
Drug Use For Unknown Indication	14.9%
Depression	8.7%
Schizophrenia	7.9%
Bipolar Disorder	7.3%
Psychotic Disorder	4.2%
Hypertension	3.2%
Pain	2.9%
Anxiety	2.5%
Schizoaffective Disorder	2.2%
Insomnia	2.0%
Schizophrenia, Paranoid Type	2.0%
Parkinson's Disease	1.9%
Constipation	1.7%
Gastrooesophageal Reflux Disease	1.5%
Crohn's Disease	1.4%
Major Depression	1.4%
Diabetes Mellitus	1.3%
Bipolar I Disorder	1.2%
Affective Disorder	1.1%

Weight Increased	8.5%
Tremor	8.3%
Death	7.9%
Vomiting	7.0%
Psychotic Disorder	6.6%
White Blood Cell Count Decreased	5.9%
Toxicity To Various Agents	4.7%
Treatment Noncompliance	4.7%
Drug Interaction	4.5%
White Blood Cell Count Increased	4.5%
Overdose	4.3%
Suicidal Ideation	4.3%
Tachycardia	4.3%
Hypertension	3.8%
Weight Decreased	3.8%
Somnolence	3.6%
Completed Suicide	3.4%
Rash	3.4%
Drug Ineffective	3.2%
Renal Impairment	3.0%

Interacting

Product Used For Unknown Indication	28.5%
Bipolar Disorder	15.5%
Depression	7.6%
Drug Use For Unknown Indication	4.3%
Schizophrenia	4.3%
Hiv Infection	3.8%
Psychotic Disorder	3.8%
Deep Vein Thrombosis	3.6%
Dyslipidaemia	3.6%
Pain	3.5%
Antiretroviral Therapy	2.9%
Hypertension	2.9%
Bipolar I Disorder	2.3%
Mania	2.3%
Smoking Cessation Therapy	2.3%
Anaesthesia	2.0%
Mood Altered	1.8%
Anxiety	1.7%
Bronchopneumonia	1.7%
Diabetes Mellitus	1.7%